Search filters

List of works by Dorota Zarębska-Michaluk

Annex #1 as of 8 June 2020 to: Management of SARS-CoV-2 infection: recommendations of the Polish Association of Epidemiologists and Infectiologists as of March 31, 2020

scientific article published on 08 June 2020

Assessment of selected clinical factors as predictors of response to combined interferon-alpha plus ribavirin therapy among patients with chronic hepatitis C.

scientific article

Assessment of the usefulness of combination of selected clinical and demographic parameters in prediction of the severity of liver fibrosis in patients with chronic hepatitis C

scientific article

Changes in patient profile, treatment effectiveness, and safety during 4 years of access to interferon-free therapy for hepatitis C virus infection

scientific article published on 07 February 2020

Comparative effectiveness of 8 versus 12 weeks of Ombitasvir/Paritaprevir/ritonavir and Dasabuvir in treatment-naïve patients infected with HCV genotype 1b with non-advanced hepatic fibrosis

scientific article published on 13 December 2019

Convalescent Plasma Transfusion for the Treatment of COVID-19-Experience from Poland: A Multicenter Study

scientific article published on 24 December 2020

Daclatasvir vs telaprevir plus peginterferon alfa/ribavirin for hepatitis C virus genotype 1

scientific article published on March 2016

Dermatologic adverse events of protease inhibitor-based combination therapy in patients with chronic hepatitis C

scientific article

Distribution of HCV genotypes in Poland

scientific article published in January 2013

Effect of COVID-19 on Anti-S Antibody Response in Healthcare Workers Six Months Post-Vaccination

scientific article published on 15 November 2021

Effect of Peginterferon or Ribavirin Dosing on Efficacy of Therapy With Telaprevir in Treatment-Experienced Patients With Chronic Hepatitis C and Advanced Liver Fibrosis: A Multicenter Cohort Study.

scientific article

Effect of comedication on ombitasvir/paritaprevir/ritonavir ± dasabuvir ± ribavirin therapy in chronic hepatitis C - a real-world study

scientific article published on 05 September 2019

Effectiveness and Safety of Pangenotypic Regimens in the Most Difficult to Treat Population of Genotype 3 HCV Infected Cirrhotics

scientific article

Effectiveness and safety of ledipasvir/sofosbuvir±ribavirin in the treatment of HCV infection: The real-world HARVEST study.

scientific article published on 26 May 2017

Effectiveness of Tocilizumab with and without Dexamethasone in Patients with Severe COVID-19: A Retrospective Study

scientific article published in 2021

Effectiveness of antiviral treatment of patients with chronic hepatitis C (a Polish multicenter study)

scientific article published on October 1, 2001

Efficacy of HCV treatment in Poland at the turn of the interferon era - the EpiTer study

scientific article published on 28 November 2016

Efficacy of combined antiviral therapy with interferon alfa and ribavirin in chronic hepatitis C patients with extrahepatic manifestations

scientific article

Factors influencing the failure of interferon-free therapy for chronic hepatitis C: Data from the Polish EpiTer-2 cohort study

scientific article published on 01 May 2021

HCV Genotype Has No Influence on the Incidence of Diabetes—EpiTer Multicentre Study

scientific article published on 13 January 2022

Hepatitis C Infection as a Risk Factor for Hypertension and Cardiovascular Diseases: An EpiTer Multicenter Study

scientific article published in September 2022

How close are we to hepatitis C virus elimination in Central Europe?

scientific article published on 17 February 2020

Is Interferon-Based Treatment of Viral Hepatitis C Genotype 3 Infection Still of Value in the Era of Direct-Acting Antivirals?

scientific article published in February 2018

Is an 8-week regimen of glecaprevir/pibrentasvir sufficient for all HCV infected patients in the real-world experience?

scientific article published on 10 November 2020

Knowledge is coming so fast that a meta-analysis of COVID-19 treatment is always too late

scientific article published on 30 September 2020

Low risk of HBV reactivation in a large European cohort of HCV/HBV coinfected patients treated with DAA

scientific article published on 13 June 2020

Management of SARS-CoV-2 infection: recommendations of the Polish Association of Epidemiologists and Infectiologists. Annex no. 2 as of October 13, 2020

scientific article published on 29 October 2020

Management of hepatitis B and hepatitis C coinfection: an expert review

scientific article published on 24 June 2020

Megamitochondria formation in hepatocytes of patient with chronic hepatitis C - a case report

scientific article published on 12 June 2017

Pangenotypic and Genotype-Specific Antivirals in the Treatment of HCV Genotype 4 Infected Patients with HCV Monoinfection and HIV/HCV Coinfection

scientific article published on 13 January 2022

Pegylated interferon-alfa 2a with ribavirin in chronic viral hepatitis C (final report)

scientific article

Perspectives of hepatitis C virus (HCV) elimination in Poland

scientific article published on 05 September 2019

Predictors of sustained virological response in patients with hepatitis C virus genotype 3 infection

scientific article published on 26 September 2016

Prevalence of HCV genotypes in Poland - the EpiTer study

scientific article published on 28 November 2016

Progress of liver disease in chronic hepatitis C patients who failed antiviral therapy

scientific article published on 01 August 2003

Real World Experience of Chronic Hepatitis C Retreatment with Genotype Specific Regimens in Nonresponders to Previous Interferon-Free Therapy

scientific article published on 03 March 2019

Real life results of direct acting antiviral therapy for HCV infection in HIV-HCV-coinfected patients: Epi-Ter2 study

scientific article published on 25 July 2019

Real-world experience with Grazoprevir/Elbasvir in the treatment of previously "difficult to treat" patients infected with hepatitis C virus genotype 1 and 4.

scientific article

Recommendations of management in SARS-CoV-2 infection of the Polish Association of Epidemiologists and Infectiologists

scientific article published on 31 March 2020

Remdesivir Decreases Mortality in COVID-19 Patients with Active Malignancy

scientific article published on 28 September 2022

Remdesivir-based therapy improved recovery of patients with COVID-19 in the SARSTer multicentre, real-world study

scientific article published on 31 December 2020

Retreatment of symptomatic hepatitis C virus genotype 3 associated mixed cryoglobulinemia with sofosbuvir and ribavirin: a case report

scientific article published on 25 May 2018

Searching for the optimal population for hepatitis C virus screening in Poland

scientific article published on 30 April 2020

Severe Breakthrough COVID-19 Cases during Six Months of Delta Variant (B.1.617.2) Domination in Poland

scientific article published on 4 April 2022

Severe intrahepatic cholestasis and liver failure after stanozolol usage - case report and review of the literature

scientific article published on 30 April 2015

The efficacy of paritaprevir/ritonavir/ombitasvir+dasabuvir and ledipasvir/sofosbuvir is comparable in patients who failed interferon-based treatment with first generation protease inhibitors - a multicenter cohort study

scholarly article by Ewa Janczewska et al published 16 November 2018 in BMC Infectious Diseases

The impact of coexisting diseases on the course of chronic hepatitis C

scientific article

Tocilizumab Improves the Prognosis of COVID-19 in Patients with High IL-6

scientific article published on 9 April 2021

Tocilizumab for patients with severe COVID-19: a retrospective, multi-centre study

scientific article published on 22 July 2020

Treatment of acute hepatitis C

scientific article published on 01 August 2003

Viral hepatitis C treatment shortening - what is the limit?

scientific article published on 20 September 2019

[Rate of liver fibrosis progression among patients with chronic hepatitis C in Poland]

scientific article published on 01 August 2003

Paulina is supported by:

About Paulina

Help